Accordingly, in this study, we discovered a suitable marker, MIR302CHG, among many known and unknown iPSC markers, for the detection of residual hiPSCs and developed assays to confirm the absence of residual undifferentiated hiPSCs intermingled in hiPSC-derived NPC populations. Here, MIR302CHG is linked to nasopharyngeal carcinoma.